Join to View Full Profile
3600 N Interstate AvePortland, OR 97227
Phone+1 503-285-9321
Fax+1 503-331-6505
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Rarick, MD is an oncologist in Portland, Oregon. He is currently licensed to practice medicine in Oregon, Washington, and California.
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 1983 - 1985
Ohio State University HospitalResidency, Internal Medicine, 1980 - 1983
Keck School of Medicine of the University of Southern CaliforniaClass of 1980
Certifications & Licensure
CA State Medical License 1983 - Present
OR State Medical License 1991 - 2025
WA State Medical License 1997 - 2016
OH State Medical License 1981 - 1984
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 10 citationsErratum: A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreat...Bert H. O'Neil, Aaron Scott, W. W. Ma, Steven J. Cohen, Dara L. Aisner
Annals of Oncology. 2016-06-18 - 20 citationsA phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metast...Bert H. O'Neil, A. J. Scott, W. W. Ma, Steven J. Cohen, Lawrence Leichman
Annals of Oncology. 2015-12-01 - 21 citationsA phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metast...B H O'Neil, A J Scott, W W Ma, S J Cohen, D L Aisner
Annals of Oncology. 2015-09-01
